Translational Development Acquisition Corp. (TDACU) Net Cash Flow (2024 - 2026)
Translational Development Acquisition's (TDACU) quarterly Net Cash Flow came in at -$5157.0 in Q1 2026, up 97.77% YoY from -$2607.5 in Q1 2025, and up 70.3% on a QoQ basis from -$17363.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Net Cash Flow (2024 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 3 years of Net Cash Flow data on file, last reported at -$5157.0 in Q1 2026.
- Quarterly Net Cash Flow rose 97.77% year-over-year to -$5157.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281970.0 (down 100.16% YoY) and the FY2025 annual result came in at -$408387.0, down 193.63% from the prior year.
- Net Cash Flow climbed to -$5157.0 in Q1 2026, from -$17363.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $174.4 million in Q4 2024 to a low of -$231574.0 in Q1 2025.
- A 3-year average of $24.9 million and a median of -$17363.0 in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow plunged 145.77% — and 2026, when it soared 97.77%.
- Tracing TDACU's Net Cash Flow over 3 years: stood at $174.4 million in 2024, then plunged by 100.01% to -$17363.0 in 2025, then surged by 70.3% to -$5157.0 in 2026.
- The last three Net Cash Flow figures came in at -$5157.0 (Q1 2026), -$17363.0 (Q4 2025), and -$88105.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,157.00 |
| Mar 31, 2026 | -5,157.00 |
| Dec 31, 2025 | -17,363.00 |
| Dec 31, 2025 | -17,363.00 |
| Sep 30, 2025 | -88,105.00 |
| Sep 30, 2025 | -88,105.00 |
| Jun 30, 2025 | -171,345.00 |
| Jun 30, 2025 | -171,345.00 |
| Mar 31, 2025 | -231,574.00 |
| Mar 31, 2025 | -231,574.00 |
| Dec 31, 2024 | 174.44 Mn |
| Dec 31, 2024 | 174.44 Mn |
| Sep 30, 2024 | 192,500.00 |
| Sep 30, 2024 | 192,500.00 |